Laddar Evenemang
Virtual Evenemang Virtual Evenemang
  • Detta evenemang har redan ägt rum.

How can live bacteria prevent and treat disease?– general aspects and recent advances on the development of Live Biotherapeutic Products (LBPs)

Program

  • Welcome and introduction
  • Population-based microbiome profiling for identification of the optimal LBPs, Lars Engstrand
  • Taking an LBP to the market, Anne-Sophie Sundström
  • Lactic Acid Bacterial based LBP’s – Preclinical research, Product development and early phase Clinical testing, Stefan Roos
  • Discussion
  • Summary and closing

Live Biotherapeutic Products (LBPs) are a cutting-edge class of therapies that harness live microorganisms, particularly bacteria, to promote health and treat diseases. By modulating the microbiome—the complex community of microorganisms in our bodies—LBPs can restore balance, enhance immune function, and target specific health conditions. They represent a promising frontier in medicine, offering potential applications for chronic diseases, gastrointestinal disorders, and beyond, by leveraging the natural interactions between our bodies and beneficial microbes.

Join us for an insightful program on the revolutionary role of live bacteria in disease prevention and treatment through LBPs. Gain valuable knowledge from leading experts who will discuss population-based microbiome profiling for optimizing LBPs, insights on bringing the innovative LBPs to market as well as preclinical research and early-phase clinical testing LBPs and engage in discussions that explore the latest advancements and applications in this exciting field.

Don’t miss this opportunity to learn about the potential of LBPs in transforming healthcare.

Speaker

Lars Engstrand, Professor, MD, senior consultant Director, Centre for Translational Microbiome Research, CTMR Karolinska Institutet

Anne-Sophie Sundström, Senior Product Development Manager, Ferring Pharmaceuticals A/S

Stefan Roos, Adjunct Professor SLU, Swedish University of Agricultural Sciences, Director Preclinic & Discovery, BioGaia AB and Co-founder and associated to Ilya Pharma AB

This is organized by section of drug formulation, this will be conducted in English!

Time & place

27 november
Kl. 17.00-19.00
Via zoom!